Dr Julie Gerberding was named FNIH’s CEO to rebuild their approach to amplify the patient’s voice across all of the FNIH’s programs to provide greater impact on both science and patient outcomes.
Lead Webcast
![Rebuilding FNIH’s Approach to Patient Engagement as a Core Part of the Organization](https://d38uvx7mib76ry.cloudfront.net/public/images/wTBKTO7lE1tCrhl6s2spavsOHtlsXUdWfcQLKZkl.png)
Dr Julie Gerberding was named FNIH’s CEO to rebuild their approach to amplify the patient’s voice across all of the FNIH’s programs to provide greater impact on both science and patient outcomes.